The revenue from antiretroviral drug formulations of Aurobindo Pharma Limited in fiscal year 2024 was around nine billion Indian rupees. This was a decrease from the previous financial year.
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2024
(in billion Indian rupees)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Aurobindo Pharma. (August 2, 2024). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees)." Chart. August 2, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. (2024). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from Antiretroviral Drug Formulations by Aurobindo Pharma Limited from Financial Year 2013 to 2024 (in Billion Indian Rupees)." Statista, Statista Inc., 2 Aug 2024, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma, Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees) Statista, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/ (last visited November 21, 2024)
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees) [Graph], Aurobindo Pharma, August 2, 2024. [Online]. Available: https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/